EXI3:XETRA:XETRA-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 401.25

Change

-13.40 (-3.23)%

Market Cap

USD 0.30B

Volume

2.59K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.21 (-2.55%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-3.43 (-3.24%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.64 (-2.61%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.33 (-2.38%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.16 (-2.95%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.78 (-3.22%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.48 (-3.48%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.19 (+0.36%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.32 (-3.10%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.21 (-0.17%)

USD 12.26B

ETFs Containing EXI3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.22% 32% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.22% 32% F 32% F
Trailing 12 Months  
Capital Gain 12.85% 68% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.85% 68% D+ 66% D+
Trailing 5 Years  
Capital Gain 69.81% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.81% 75% C 73% C
Average Annual (5 Year Horizon)  
Capital Gain 13.53% 76% C+ 74% C
Dividend Return 13.95% 76% C+ 74% C
Total Return 0.42% 38% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 11.05% 58% F 66% D+
Risk Adjusted Return 126.21% 99% N/A 98% N/A
Market Capitalization 0.30B 60% D- 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.